Table 2.
Study characteristics.
| ||||||||
---|---|---|---|---|---|---|---|---|
STUDY & COUNTRY [REFERENCE] | TARGET POPULATION | INTERVENTION | PROGRAMME CONTENTS | N (INTERVENTION, CONTROL)*1 | SETTING | DATA COLLECTION PERIOD | STUDY TYPE (ANALYSES) | OUTCOMES |
| ||||||||
Bhatt, S.P.
United States [28] |
COPD | Bundle*2 | Post-acute care bundle: antibiotics, educational materials, interval follow-up, and periodic phone calls | 78, 109 | Secondary (hospital) care | 2012 vs. 2014 | Cohort study with control group (independent sample statistical tests) | HR, EDV, Vis, HC, LoS |
| ||||||||
Koehler, B.E.
United States [29] |
PwM | Bundle | Elderly care bundle designed as an intensive patient-centred educational programme. Includes daily visits during hospital stay, standardised phone calls for follow-up appointments and education, and medication verification post discharge | 22,20 | Secondary (hospital) care | 2007 | Randomised control trial (independent sample statistical test) | HR, LoS |
| ||||||||
Morton, K.
United Kingdom [30] |
COPD | Bundle | COPD discharge bundle: technique (inhalers), action plan, pulmonary rehabilitation, smoking cessation, and specialist follow up. | 4657, 4515 | Secondary (hospital) care | 2013–2017 | Pre-post study with control group (regression models) | Mor, HR, EDV, LoS |
| ||||||||
Parekh, T.M.
United States [31] |
COPD | Bundle*2 | Post-acute care bundle: expedited follow-up visits in a COPD focused clinic, home calls, medication assistance, and tobacco cessation counselling. | 459, 239 | Secondary (hospital) care | 2012–2014 | Cohort study with control group (independent sample statistical tests) | Mor, HR, EDV, HC, LoS |
| ||||||||
Pawaskar, M.
United States [32] |
Diabetes | Capitation | Managed care organisations receive a fixed amount of payment per enrolee per month | 3763, 4818 | Primary care, secondary (hospital) care |
1999–2005 | Cohort study with control group (regression models) | ADU, Hos, EDV, Vis |
| ||||||||
Quinn, A.E.
Canada [33] |
Diabetes, CKD | Capitation | A salary-like payment that covered clinical, research, and teaching time |
15949, 15949 | Secondary (hospital) care | 2011–2015 | Cohort study with matched control group (regression) | DRE, Hos, EDV, Vis, HC |
| ||||||||
Joynt Maddox United States [21] CHF, COPD |
DRG*2 | BPCI-model 2 bundle: Participating hospitals assume accountability for the costs of all care within 30, 60, or 90 days after hospitalisation for one or more of 48 conditions | 226, 407 hospitals | Secondary (hospital) care | 2013–2015 | Pre-post study with matched control group (regression models) | Mor, HR, EDV, HC, LoS | |
| ||||||||
Kutz, A.
Switzerland [34] |
COPD | DRG | All costs related to all acute inpatient hospital services | 19046, 30764 | Secondary (hospital) care | 2009–2015 | Pre-post study without control group (regression models) | Mor, HR, LoS |
| ||||||||
Lichkus, J.
United States [35] |
CHF | DRG*2, 3 | One bundled payment per 90-day episode of care initiated by an anchor admission for CHF exacerbation. |
283, 316 | Secondary (hospital) care | 2013–2017 | Pre-post study without control group (t-tests) | HR, HC |
| ||||||||
Maughhan, C.
United States [36] |
Dementia | DRG*2 | BPCI-model 2 bundle: Participating hospitals assume accountability for the costs of all care within 30, 60, or 90 days after hospitalisation for one or more of 48 conditions. | 45007, 45007 episodes | Secondary (hospital) care | 2011–2012 & 2013–2016 | Pre-post study with matched control group (regression models) | Mor, HR, EDV |
| ||||||||
Salzberg, C.A.
United States [37] |
Diabetes | Global budget*3 | Primary care practices receive a monthly, risk-adjusted total payment for the comprehensive care of all patients in the practice |
64471, 133345 | Primary care | 2008–2013 | Pre-post study with matched control group (regression models) | HR, Hos, EDV, Vis, HC |
| ||||||||
Cross, D.A.
United States [38] |
PwM | P4P | P4P-programme with incentives linked to 1) Medical Home Practice Transformation, 2) Provider-delivered Care Management, and 3) Practice Quality Assessment | 17501, 195344 | Primary care | 2010–2013 | Cohort study with control group (regression models) | DRE, ADU, HR, Hos, EDV, Vis, HC |
| ||||||||
Hollander, M.J.
Canada [39] |
Diabetes, CHF, COPD | P4P | P4P-programme with incentives linked to the provision of guidelines-based care to patients with chronic conditions | 176542, 209064 | Primary care | 2010–2011 | Cohort study with matched control group (paired samples t-test) | HR, Hos, HC |
|
*1 Total number included in analyses relevant to this study – patients unless indicated otherwise.
*2 Part of Bundled Payments for Care Improvement (BPCI) Initiative.
*3 Payment reform is accompanied by an organisational reform.
COPD: Chronic obstructive pulmonary disease, PwM: Patients with multimorbidity, CHF: Chronic health failure, CKD: Chronic kidney disease.
DRE: Disease related examination(s)/treatment(s), ADU: Appropriate drug use, Mor: Mortality, HR: Hospital readmissions, Hos: Hospitalisations, EDV: Emergency Department Visits, Vis: Visits, HC: Healthcare costs, LoS: Length of Stay.